The MAFB / IGH t(14;20) Fusion FISH probe hybridized to patient material showing a complex pattern with a t(14;20) translocation. Image kindly provided by Erasmus Medical Center, Rotterdam.
The MAFB / IGH t(14;20) Fusion FISH probe hybridized to patient material showing a complex pattern with a t(14;20) translocation. Image kindly provided by Erasmus Medical Center, Rotterdam.
IVD MAFB /IGH
The immunoglobulin heavy chain (IGH) gene at 14q32 is an important cause of genetic deregulation in MM. Among the known fusion partners for the IGH (previously known as IGH@) gene, reciprocal translocation with the MAFB gene at 20q12 is relatively rare in MM (~2% occurrence). However, the MAFB/IGH t(14;20) translocation is associated with poor prognosis in multiple myeloma patients. The MAFB/IGH t(14;20) Fusion FISH probe is optimized to detect the reciprocal translocation t(14;20) in a dual-color, dual-fusion assay on metaphase/interphase spreads and bone marrow cells.
References: Boersma-Vreugdenhil GR et al, 2004, Br J Haematol, 126; 355-363. Bergsagel PL et al, 2005, JCO, 23; 6333-6338.
Produkte
Produkte
KBI-10510
MAFB/IGH t(14;20) Fusion
Product is out of stock
Due to manufacturing & supply chain issues, this product is currently unavailable. You may place your order and it will be fulfilled when the product is back in stock. For more help, please reach out to customer service at +1 844 534 2262 or nonurgentcs@leicabiosystems.com
Product is limited in stock
Product availability is limited, but products are in continuous production. Your order will be processed as normal and may take additional days to ship.